“Alan Cowman is recognised globally as a pre-eminent malaria researcher.
He has made an enormous impact on infectious disease research, changing
people’s lives and health outcomes
through his significant research breakthroughs."
So begins the citation that led to Professor Cowman being honoured with the most prestigious
award of the Australian Society for Biochemistry and Molecular Biology, the Lemberg Medal.
The citation continues: “[Professor Cowman] works in a highly competitive field on an organism that is
notoriously difficult to manipulate and [he] publishes in prestigious international journals advancing
understanding, knowledge and strategies to combat this devastating disease. The Cowman laboratory’s
innovative and pioneering work … has driven the development of new technologies and opened up
fresh avenues of investigation, discovery [and] knowledge that is essential in identifying the
most appropriate vaccine and drug targets for the development of new therapeutics against malaria.”
Professor Nick Nicola, Acting Director of WEHI, said, “It is estimated that malaria infects and debilitates
up to 10% of all humanity: about 500,000,000 people, mainly in the wet tropical regions of the world.
Tragically, up to three million people may die from malaria every year. Malaria is a continuing global
pandemic, on a scale comparable to HIV/AIDS and tuberculosis. WEHI - and indeed the world - is
fortunate to have scientists of the calibre of Professor Cowman and his colleagues pursuing
innovative approaches to deal with this appalling disease.”
Professor Cowman is the Head of WEHI’s Division of Infection and Immunity. His previous honours
include the Gottschalk Medal for Medical Science and Biology from the Australian Academy of Sciences
and (twice) an International Research Scholarship from the Howard Hughes Medical Institute, USA. He
is also a Fellow of the Australian Academy of Science.